膀胱的辐射剂量-体积效应。
Radiation dose-volume effects of the urinary bladder.
机构信息
Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.
出版信息
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S116-22. doi: 10.1016/j.ijrobp.2009.02.090.
Abstract
An in-depth overview of the normal-tissue radiation tolerance of the urinary bladder is presented. The most informative studies consider whole-organ irradiation. The data on partial-organ/nonuniform irradiation are suspect because the bladder motion is not accounted for, and many studies lack long enough follow-up data. Future studies are needed.
摘要
本文深入概述了膀胱的正常组织辐射耐受能力。最有参考价值的研究考虑了整个器官的照射。部分器官/不均匀照射的数据是值得怀疑的，因为没有考虑到膀胱的运动，而且许多研究缺乏足够长的随访数据。需要进一步研究。
相似文献
1
Radiation dose-volume effects of the urinary bladder.膀胱的辐射剂量-体积效应。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S116-22. doi: 10.1016/j.ijrobp.2009.02.090.
2
[The tolerance dose of the urinary bladder].
Gan No Rinsho. 1987 Aug;33(10):1184-8.
3
[Normal tissue tolerance to external beam radiation therapy: bladder].
Cancer Radiother. 2010 Jul;14(4-5):363-8. doi: 10.1016/j.canrad.2010.02.007. Epub 2010 May 21.
4
Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study.自适应三维适形放疗治疗前列腺癌后慢性泌尿系统毒性的预测因素：一项II期剂量递增研究的剂量体积分析
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1100-9. doi: 10.1016/j.ijrobp.2007.04.076.
5
Bladder and intestinal injuries following intracavitary irradiation of carcinoma of the uterine cervix.
Acta Radiol Ther Phys Biol. 1974 Aug;13(4):288-96. doi: 10.3109/02841867409134482.
6
Rectal and Urethro-Vesical Subregions for Toxicity Prediction After Prostate Cancer Radiation Therapy: Validation of Voxel-Based Models in an Independent Population.前列腺癌放射治疗后毒性预测的直肠和尿道-膀胱亚区：基于体素模型在独立人群中的验证。
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1189-1195. doi: 10.1016/j.ijrobp.2020.07.019. Epub 2020 Jul 13.
7
[Prognosis in radiation injuries of the bladder and rectum in patients with cancer of the cervix uteri].
Med Radiol (Mosk). 1984 Jan;29(1):54-7.
8
9
Rectal and bladder injuries in relation to radiation dosage in carcinoma of the cervix. A 5 year follow-up.
Am J Obstet Gynecol. 1961 Jul;82:74-82. doi: 10.1016/s0002-9378(16)36097-5.
10
Radiation-induced impairment of urinary bladder function. Assessment of micturition volumes.辐射诱导的膀胱功能损伤。排尿量评估。
Strahlenther Onkol. 1998 Nov;174 Suppl 3:96-8.
引用本文的文献
1
Implementation of intelligent All-in-one technology in rectal cancer radiotherapy: A retrospective study on automation efficiency and safety.智能一体化技术在直肠癌放疗中的应用：自动化效率与安全性的回顾性研究
J Appl Clin Med Phys. 2025 Sep;26(9):e70236. doi: 10.1002/acm2.70236.
2
Dosimetric and Radiobiological Comparison of Three-Dimensional Conformal Radiotherapy and Helical Tomotherapy in Whole Pelvic Radiotherapy of Prostate Cancer Patients.前列腺癌患者全盆腔放疗中三维适形放疗与螺旋断层放疗的剂量学和放射生物学比较
J Biomed Phys Eng. 2025 Aug 1;15(4):333-340. doi: 10.31661/jbpe.v0i0.2301-1587. eCollection 2025 Aug.
3
Clinical Guidelines for the Prevention and Treatment of Radiation-induced Bladder Injury.放射性膀胱损伤防治临床指南
Precis Radiat Oncol. 2024 Feb 8;8(1):4-13. doi: 10.1002/pro6.1215. eCollection 2024 Mar.
4
Can the Dose Constraints Be Trusted? Actual Dose Exposure of Bladder and Rectum During Prostate Cancer Radiotherapy.剂量限制值得信赖吗？前列腺癌放疗期间膀胱和直肠的实际剂量暴露情况。
Cancers (Basel). 2025 Mar 31;17(7):1194. doi: 10.3390/cancers17071194.
5
Bowel Disorder Incidence and Rectal Spacer Use in Patients With Prostate Cancer Undergoing Radiotherapy.接受放疗的前列腺癌患者的肠道疾病发生率及直肠间隔器的使用情况
JAMA Netw Open. 2025 Mar 3;8(3):e250491. doi: 10.1001/jamanetworkopen.2025.0491.
6
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer.非转移性前列腺癌放疗后晚期膀胱毒性的多基因风险评分
Cancer Epidemiol Biomarkers Prev. 2025 May 2;34(5):795-804. doi: 10.1158/1055-9965.EPI-24-1228.
7
Dosimetric effects of bladder volume changes in MR-guided radiotherapy for cervical cancer.宫颈癌磁共振引导放疗中膀胱体积变化的剂量学效应
BMC Cancer. 2025 Feb 21;25(1):324. doi: 10.1186/s12885-025-13442-3.
8
Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity.迈向盆腔癌的个性化放疗：晚期放射毒性的患者相关风险因素
Curr Oncol. 2025 Jan 17;32(1):47. doi: 10.3390/curroncol32010047.
9
Stereotactic Body Radiation Therapy (SBRT) in prostate cancer in the presence of hip prosthesis - is it a contraindication? A narrative review.立体定向体部放射治疗（SBRT）在存在髋关节假体的前列腺癌中的应用 - 是否为禁忌症？叙述性综述。
BMC Urol. 2024 Jul 26;24(1):152. doi: 10.1186/s12894-024-01479-8.
10
Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume: A Treatment-planning Study Based on the HYPO-RT-PC Fractionation Schedule.针对前列腺癌的超分割放疗，靶区包括精囊：一项基于HYPO-RT-PC分割方案的治疗计划研究
Adv Radiat Oncol. 2024 Apr 30;9(7):101531. doi: 10.1016/j.adro.2024.101531. eCollection 2024 Jul.
本文引用的文献
1
Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.荷兰局部前列腺癌放疗多中心剂量递增试验的最新情况。
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):980-8. doi: 10.1016/j.ijrobp.2008.02.073. Epub 2008 May 19.
2
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.局限性前列腺癌三维适形放疗和调强放疗后晚期直肠和泌尿系统毒性反应的发生率
Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1124-9. doi: 10.1016/j.ijrobp.2007.11.044.
3
Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes.局部前列腺癌的超高剂量（86.4 Gy）调强放射治疗：毒性反应及生化指标结果
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):330-7. doi: 10.1016/j.ijrobp.2007.10.004. Epub 2007 Dec 31.
4
Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.与泌尿生殖系统并发症不同，前列腺癌三维适形放射治疗后的晚期胃肠道并发症会随时间逐渐减轻。
Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1478-86. doi: 10.1016/j.ijrobp.2007.08.076. Epub 2007 Dec 3.
5
Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience.保留膀胱的联合治疗方法用于肌层浸润性膀胱癌：一项多机构长期经验
Cancer. 2008 Jan 1;112(1):75-83. doi: 10.1002/cncr.23137.
6
Urodynamic and ultrasound characteristics of incontinence after radical hysterectomy.根治性子宫切除术后尿失禁的尿动力学和超声特征
Neurourol Urodyn. 2007;26(6):794-9. doi: 10.1002/nau.20431.
7
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy.接受辅助性或挽救性放疗的前列腺癌患者晚期泌尿生殖系统和胃肠道毒性的预测因素。
Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1417-23. doi: 10.1016/j.ijrobp.2007.01.049. Epub 2007 Apr 6.
8
Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer.评估减少高剂量体积对膀胱癌放射治疗毒性的影响。
Clin Oncol (R Coll Radiol). 2006 Aug;18(6):466-73. doi: 10.1016/j.clon.2006.04.008.
9
Deformable structure registration of bladder through surface mapping.通过表面映射实现膀胱的可变形结构配准。
Med Phys. 2006 Jun;33(6):1848-56. doi: 10.1118/1.2198192.
10
Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer.磁共振引导下的子宫内膜癌阴道复发间质治疗
Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):91-9. doi: 10.1016/j.ijrobp.2006.04.037. Epub 2006 Jul 12.
Zotero 插件